Optimi Health to Present at the Sidoti Micro-Cap Conference on January 21-22, 2026

Core Insights - Optimi Health Corp. is a leading producer of prescribed psychedelic treatments for mental health therapies, and it has been invited to present at the Sidoti Micro-Cap Virtual Conference on January 21-22, 2026 [1][4]. Company Overview - Optimi Health Corp. is a Health Canada-licensed and GMP compliant pharmaceutical manufacturer, producing validated MDMA and botanical psilocybin products from two facilities in British Columbia, each spanning 10,000 square feet [4]. - The company supplies active pharmaceutical ingredients and finished dosage forms to regulated channels, with products currently available for prescription use in Australia and accessible in Canada through the Special Access Program [4]. Event Participation - CEO Dane Stevens will host virtual one-on-one meetings with institutional investors during the conference and will present on January 21, 2026, at 11:30 a.m. Eastern Time [2]. - Interested media and investors are invited to join the online presentation, with a recommendation to log in at least five minutes early for timely participation [2].